TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    Is Valeant’s Big Offer for Allergan Big Enough?

    Or is Valeant set to offer even more?

    Read more »

    The Motley Fool
    Investing

    3 Top Stock Picks From Aurion Capital

    Aurion Capital's Greg Taylor revealed his favourite stock picks. Which of them should you add to your portfolio?

    Read more »

    The Motley Fool
    Investing

    Allergan Wants Nothing to Do With Valeant’s Stock. Should You?

    Breaking down Valeant-Allergan, potentially Canada's largest-ever acquisition. The most recent edition of Take Stock is here!

    Read more »

    The Motley Fool
    Investing

    Valeant’s Pursuit of Allergan: Go Big or Go Home

    Only a very good offer will entice Allergan shareholders.

    Read more »

    The Motley Fool
    Investing

    5 Can’t-Miss Investing Headlines This Week

    Canada's job market disappoints. Valeant up the ante for Allergan. And is Sears Canada doomed?

    Read more »

    The Motley Fool
    Investing

    Will the Valeant–Allergan Merger Flop?

    It will be a major challenge for Valeant to make this work.

    Read more »

    The Motley Fool
    Investing

    3 Stocks Investors Should Consider Selling

    If you own the shares, it may be time to take some profits. If not, it may be too late…

    Read more »

    The Motley Fool
    Investing

    3 Reasons to Avoid Shares of Valeant Pharmaceuticals

    The company has done everything right over the past five years. But this may not be a bet worth taking.

    Read more »

    The Motley Fool
    Investing

    5 Stocks to Sell Before Summer

    Does your portfolio need a late spring cleaning?

    Read more »

    The Motley Fool
    Investing

    5 Stocks to Watch This Week

    This will be a huge results week for Canadian companies.

    Read more »

    The Motley Fool
    Investing

    4 Ways to Profit From the Aging Population

    Position your portfolio for the biggest demographic trend of our lives.

    Read more »

    The Motley Fool
    Investing

    3 Canadian Stocks With Russian Exposure

    Will investors feel Russian pain from these 3 companies with exposure to the country?

    Read more »